Why Exelixis (EXEL) is One of the Best Healthcare Stocks Under $50 to Invest In

Exelixis, Inc. (NASDAQ:EXEL) is 1 of the champion healthcare stocks nether $50 to put in. On February 4, Barclays revised the terms people connected Exelixis, Inc. (NASDAQ:EXEL) to $44 from $41 and maintained an Equal Weight standing connected the shares, releasing the update arsenic portion of a fiscal Q4 net preview for the biotech group.

In different development, Exelixis, Inc. (NASDAQ:EXEL) announced connected February 2 the acceptance of its New Drug Application (NDA) for zanzalintinib, successful operation with atezolizumab, for reappraisal successful the U.S. to dainty big patients with metastatic colorectal crab who person been antecedently treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, and, if RAS wild-type, an anti-epidermal maturation origin receptor therapy.

Dana T. Aftab, Ph.D., Executive Vice President, Research and Development, Exelixis, Inc. (NASDAQ:EXEL), stated that zanzalintinib holds the imaginable to go a important advancement successful a challenging attraction scenery and supply a caller mechanics of action, successful operation with atezolizumab, for patients with antecedently treated metastatic colorectal crab if it is approved. Management reported that the Food and Drug Administration assigned a modular reappraisal with a Prescription Drug User Fee Act people enactment day of December 3, 2026.

Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes caller medicines for difficult-to-treat cancers. Its merchandise portfolio includes cabometyx, cometriq, and cotellic.

While we admit the imaginable of EXEL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.